Numerous studies suggested that the levels of pro-inflammatory markers including TNF-α, IL-1β, and IL-6 were significantly increased in the cerebrospinal fluid of AD patients and were correlated with impairment in LTP in animal models of AD [87,88,89]. This evidence concerns the gene IL6 and Alzheimer disease.